Skip to main content
. 2023 Sep 16;50(11):9029–9036. doi: 10.1007/s11033-023-08777-8

Fig. 4.

Fig. 4

Relationship between serum biomarkers miR-675-5p, lncH19 and the severity of the disease in the study groups. a) Serum biomarkers gene expression levels in the UC group (severity is determined according to Mayo score). b) Serum biomarkers gene expression levels in the CD group (severity is determined according to CDAI score). * = p value is significant (< 0.05) against the remission stage